March 25th 2024
TriNutra has announced structure-function health claims granted by Health Canada for its proprietary black seed oil when taken as an oral supplement.
Role of vitamin K2 on cardiovascular health subject of presentation at nephrology symposium
January 6th 2023Central to the discussion was a new study that is investigating the effects of 1 mg of MenaQ7 Vitamin K2 as MK-7 from Gnosis by Lesaffre versus placebo on arterial stiffness and the occurrence of cardiovascular events in end-stage renal disease patients undergoing peritoneal dialysis over the course of 1.5 years.
Conagen has developed high purity, non-GMO sulforaphane
December 6th 2022Sulforaphane is found in cruciferous vegetables such as arugula, bok choy, broccoli, Brussels sprouts, cabbage, kale, and radish, to name a few, and is associated with supporting metabolic health, digestion, heart health, and cognitive health.
FDA sends warning letters to dietary supplement companies claiming to treat cardiovascular disease
November 18th 2022On November 17, the agency sent warning letters to Essential Elements, Calroy Health Sciences, Iwi, BergaMet North America, Healthy Trends Worldwide, Chambers’ Apothecary, and Anabolic Laboratories.
Vitamin K2 and D supplementation reduces risk of coronary artery calcification, says recent study
October 12th 2022A subgroup analysis of the Aortic Valve Decalcification Trial (AVADEC study) observed that vitamin K2 MK-7 (720 µg/day) and D (25 µg/day) supplementation for two years helped slow the progression of coronary plaque development in individuals at high risk of developing coronary artery calcification